Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials is a research paper published in Nature Reviews Drug Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 565 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA154923
NCI NIH HHS
Grant: R01 CA215118
NCI NIH HHS
Grant: P01 CA163222
NHLBI NIH HHS
Grant: R01 HL144780
NIH HHS
Grant: R24 OD016761
NIH HHS
Grant: R24 OD035402
European Research Council
Grant: 687306
European Consortium for Lithium-Sulfur Power for Space Environments
European Research Council
Grant: 648489
Chemical Biology in Zebrafish: Drug-Leads and New Targets in the Melanocyte Lineage and Melanoma
Medical Research Council
Grant: MC_UU_00007/9
Gene-drug interactions in the melanocyte lineage and melanoma
NCI NIH HHS
Grant: R01 CA211734
NCI NIH HHS
Grant: R01 CA103846
NCI NIH HHS
Grant: R01 CA226926
National Institutes of Health
Grant: 5R01CA226926-02
New models and therapeutic approaches in alveolar rhabdomyosarcoma
National Institutes of Health
Grant: 1R01CA154923-01
Genetics of Rhabdomyosarcoma
National Institutes of Health
Grant: 5R01CA211734-05
Oncogenic pathways and therapeutic targets in T cell acute lymphoblastic leukemia
National Institutes of Health
Grant: 5R01CA215118-04
Stem cell self-renewal programs in rhabdomyosarcoma
European Commission
Grant: 215118
BRAssinosteroid Venture Increasing StudentS' International MObility
National Institutes of Health
Grant: 5R01CA103846-15
Cancer biology in the zebrafish
National Institutes of Health
Grant: 5R24OD016761-07
Immune Compromised Zebrafish for Cell Transplantation
FWCI
33.13
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 4 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 4 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 5 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 5 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 3 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 2 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 2 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 1 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 1 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Additional file 3 of Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor